World Association of Societies of Pathology and Laboratory Medicine

Disclaimer:
Information regarding a non-State actor, contained in the section “Non-State Actors Profiles” in the Register, has been provided by that non-State actor itself, and the accuracy and completeness of such information is the sole responsibility of that non-State actor, not WHO. In turn, information in the sections “WHO’s Engagement” and “Non-State Actors in Official Relations” has been provided by WHO, subject to certain conditions. All access and use of any section of the Register is governed by the Terms and Conditions of Use.

 Overview

World Association of Societies of Pathology and Laboratory Medicine
WASPaLM
A global network of physician-led Societies of Pathology and Laboratory Medicine
http://www.waspalm.com
13 Oct 2021 11:15:11 AM

 General information

World Association of Societies of Pathology and Laboratory Medicine
WASPaLM
WASPaLM
World Association of Societies of Pathology and Laboratory Medicine
WASPaLM
A global network of physician-led Societies of Pathology and Laboratory Medicine
Via Farini 81 c/o MZ Congressi
Milano
Italy
20100
Italy
waspalm@mzcongressi.com
http://www.waspalm.com

 Governance

Registered not-for-profit corporation
1947
Bureau
Roberto Verna
President
Professor of Clinical Pathology Sapienza University of Roma Italy
Mariano Bizzarri
Secretary Treasurer
Professor of Clinical Pathology Sapienza University of Rome Italy
Walter Alallon
President Elect
Director Clinical Pathology Dept CASMU Montevideo Uruguay
Ozkan Alatas
Director Europe
Professor of Clinical Biochemistry Director of Clinical Laboratory in Eskisehir Osmangazi University Hospital Turkey
Catherine Hayward
Director North America
Professor of Pathology and Molecular Medicine, and Medicine, McMaster University, Hamilton Canada
Praveen Sharma
Director South East Asia
Professor of Clinical Pathology All India Institute
Nairo Sumita
Director South America
Assistant Professor of Clinical Pathology Discipline, Faculdade de Medicina da Universidade de São Paulo - FMUSP, (São Paulo University Medical School), Brazil
Hong Shang
Director Western Pacific
Professor of Medicine, Doctoral Supervisor President of the First Affiliated Hospital of China Medical University Bejing
Toshiyuky Yamada
Additional Director
Professor, Department of Clinical laboratory Medicine, Jichi Medical University
Masami Murakami
Past President
Professor and Director, Dept of Laboratory Medicine. Gunma Univ Tokyo, Japan
Management of the Association
Conduct the general business of the Association to promote its purposes
Executive Committee
Roberto Verna
President
In Unam Sapientiam University of Roma
Walter Alallon
President Elect
Director Clinical Pathology Dept CASMU Montevideo Uruguay
Mariano Bizzarri
Secretary Treasurer
Sapienza University pf Rome
Masami Murakami
Past President
Showa Gunma Univerity Tokyo
Rules the Management of the Association
House of Representatives
Two Members from each Constituent Society
Advice on policy and programmes of the Association

 Financial information

January
2020
December
2020
14,172
December
2020
0
Private sector entities (including business associations)
Philanthropic foundations
NGOs, academic institutions
Government entities, intergovernmental organizations, including UN
General public, individuals
Total
7,062
7,062
7,110
7,110
14,172
14,172
These amounts are approximate and subject to change, with payment of bills.

 Membership

Individuals
0
0
NGOs
40
32
Private sector entities
0
0
Philanthropic foundations
0
0
Academic institutions
0
0
Government entities
0
0
Intergovernmental organizations
http://www.waspalm.com/constituent-societies-links.php

Organizational Structure

No data available
No data available

Relations

No data available
No data available

  Activities

1. Extend medical knowledge
2. Further the welfare of the sick
3. Promote public health
More specifically, the purposes of the Association are to promote the practice of pathology and laboratory medicine; the development of all branches of pathology and laboratory medicine, education in pathology and laboratory medicine, and the organization of efficient pathology and laboratory medicine services; and to foster the development of and cooperation among its constituent societies and, thereby, to benefit patients and facilitate the improved understanding of disease throughout the world.
Strategic Priority 1: One billion more people benefiting from universal health coverage
Strategic Priority 2: One billion more people better protected from health emergencies
Strategic Priority 3: One billion more people enjoying better health and well-being
Strategic Priority 4: More effective and efficient WHO providing better support to countries
To extend medical knowledge;
To further the welfare of the sick & promote public health.
More specifically:to promote the practise of pathology & laboratory medicine & and to promote their development(all branches). by furthering education in pathology and laboratory medicine

  Country presence

Regions
Countries
Activities
Members
Offices / representatives
African Region
Region of the Americas
Eastern Mediterranean Region
European Region
South-East Asia Region
Western Pacific Region
Global

  Disclosure & declaration

Pursuant the WHO Framework of Engagement with Non-State Actors, WHO does not engage with the tobacco industry or non-State actors that work to further the interests of the tobacco industry. WHO also does not engage with the arms industry.

For the purposes of this statement:

  • tobacco industry means any entity involved in the manufacture, sale or distribution of tobacco and related products, and any affiliate of such entity; and
  • arms industry means any entity involved in the manufacture, sale or distribution of arms, and any affiliate of such entity.

This disclosure statement needs to be provided by any nongovernmental organization, private sector entity, philanthropic foundation and academic institution prior to engaging with WHO.

In view of the foregoing, please answer the following questions:

  1. Is your entity, or was your entity over the last four years, part of the tobacco or arms industries (as defined above)?
  1. To the best of your entity’s knowledge, is your entity, or has your entity over the last four years, engaged in activities that are aimed at furthering or supporting the interests of the tobacco industry? This includes, but is not limited to, supply contracts, contract work, services and lobbying.
  1. To the best of your entity’s knowledge, does your entity currently, or did your entity over the last four years, have any other association or relationship with the tobacco industry (as defined above). This includes in particular investment interests (other than general mutual funds or similar arrangements whereby your entity has no control over the selection of the investments), commercial business interests, the provision or receipt of financial and/or other support.
  1. If you have answered yes to any of the above or are unable to answer one or more questions, please provide a general statement of explanation.

Please note that the WHO Secretariat reserves the right to request additional information from your entity in this regard.
By providing this statement, your entity commits to promptly inform WHO of any change to the above information and to complete a new statement that describes the changes.
We are in contact with several Universities, Hostpitals and Research Centers dealing with Health Care